1. Home
  2. NSPR vs MXE Comparison

NSPR vs MXE Comparison

Compare NSPR & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.20

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

HOLD

Current Price

$13.13

Market Cap

60.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
MXE
Founded
2005
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
60.3M
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
NSPR
MXE
Price
$1.20
$13.13
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
55.0K
3.1K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
2.66%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$9.36
52 Week High
$2.93
$14.30

Technical Indicators

Market Signals
Indicator
NSPR
MXE
Relative Strength Index (RSI) 27.44 46.51
Support Level N/A $13.07
Resistance Level $2.47 $14.20
Average True Range (ATR) 0.09 0.24
MACD -0.00 -0.07
Stochastic Oscillator 34.22 31.08

Price Performance

Historical Comparison
NSPR
MXE

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: